News

Administered intravenously, the monoclonal antibody MK-2060 has a "novel approach" to anticoagulation by blocking the ...
Abstract: The residual stenosis estimation of an arteriovenous shunt is a valuable for evaluating outcomes of percutaneous transluminal angioplasty (PTA) treatment and surgical revision. This paper ...
A vein taken from another area in your leg is attached above and below the blockage. This is called a graft. The blood is rerouted through the graft around the blockage. In some cases, an artificial ...
Among other applications, we developed a tissue-engineered vascular graft (TEVG) by seeding tubular biodegradable polymeric scaffolds with autologous bone marrow–derived mononuclear cells. Results of ...
Traditional vascular grafts made of synthetic polymers, animal and cadaveric tissues, or autologous vasculature have been utilized for almost a century with well-characterized outcomes, leaving areas ...
We recently published a list of 10 AI Stocks on Latest News and Ratings. In this article, we are going to take a look at where Rivian Automotive, Inc. (NASDAQ:RIVN) stands against other best AI ...
MINNEAPOLIS, May 22, 2025 /PRNewswire/ -- Phraxis Inc., a Minneapolis -based medical device company, marks a major milestone ...
Purpose To evaluate whether a set of objective discharge criteria, including muscle strength and functional tests, are associated with risk of ACL graft rupture after RTS. Materials and methods 158 ...
When Lourenco came to power in 2017, he made fighting graft a top priority, pledging to dismantle corrupt business networks that plagued the nation under his predecessor Jose Eduardo dos Santos. The ...
ABSTRACT: Introduction: Arteriovenous fistula (AVF) operation is recognized a gold standard of hemodialysis for end-stage renal disease. Because various complications may occur during perioperative ...
It’s been 10 years since George Miller’s acclaimed franchise follow-up, Mad Max: Fury Road, premiered in theaters. If you peruse the reviews from that time, you’ll see some common responses ...